Lilly, Medtronic to deliver diabetes education
INDIANAPOLIS A drug maker and a medical device maker have announced a collaboration to provide education on care and management of diabetes.
Eli Lilly & Co. and Medtronic said their marketing and sales operations would work with healthcare professionals to deliver diabetes education for patients and caregivers affected by Type 1 diabetes, including the development of educational resources and classes around the initiation and intensive management of insulin, insulin pump therapy and continuous glucose monitoring.
“Medtronic and Lilly are joining together to help improve patient access to high-quality diabetes education,” Medtronic SVP and diabetes business unit president Chris O’Connell said. “Because diabetes management is complicated, it is crucial that physicians and patients have the best access to information and educational resources.”
Bartell Drugs sponsors ‘Stock the Pantry’ food drive
SEATTLE Bartell Drugs has announced its sponsorship of its “Stock the Pantry” food drive to benefit a local food bank.
The regional chain said it would accept donations of nonperishable food for the organization Northwest Harvest at its 55 stores in the Seattle area from June 1 to 14.
The drive is designed to benefit families that depend on free or reduced-price school lunches during the summer months, when they may struggle to provide those meals at home.
FDA tenatively approves Teva pink eye generic
ROCKVILLE, Md. The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its generic version of a drug for eye infections, FDA records showed.
The agency gave Teva the tentative approval for its moxifloxacin hydrochloride ophthalmic solution in the 0.5% strength. The solution is a generic version of Alcon’s Vigamox, which is used to treat bacterial conjunctivitis, commonly known as pink eye.
Alcon does not list the sales figures for Vigamox, though it reported sales of drugs to treat infections and inflammations of $882.5 million for 2008 in Securities and Exchange Commission filings.